Biomet Shareholders Approve Merger

It’s official. Over 91% of Biomet (BMET) shareholders approved the merger agreement with LVB Acquisition, Inc., which is the consortium of Blackstone, Goldman, KKR and TPG. The deal is for $46 a share in cash.
When the initial deal came out at $44 a share, the Internet went crazy. Actually, it was just me. But five months after my first post complaining that the offer was too low, Institutional Shareholder Services agreed. So the consortium raised the bid by $2 a share, and now, it’s a done deal.

Posted by on September 5th, 2007 at 12:42 pm


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.